readthroughSign in
CompanyOMERNasdaqSeattle, WA

Omeros Corporation

Omeros develops protein and small-molecule therapeutics targeting complement-mediated diseases, cancers, and neuropsychiatric disorders.

10-QNov 16Latest SEC filing
Nov 16Latest story